Navigation Links
Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis
Date:7/17/2008

nging trial will include three treatment arms of anastrozole, all with a fixed dose oral contraceptive in pre-menopausal women diagnosed with endometriosis. The primary endpoint is reduction in endometriosis-related symptoms, primarily pain. Secondary endpoints include quality of life, bleeding patterns and safety outcomes. The goal of the study is to provide data on efficacy and safety of MPI-676, as well as information about feasible endpoints and trial sizes for the planning and execution of the subsequent pivotal Phase III program in endometriosis.

Endometriosis is a serious medical condition where endometrial stroma and glands that are normally present in the uterine cavity are found in other parts of the body. Endometriosis lesions can be found anywhere in the pelvic cavity. The most common symptom of endometriosis is pelvic pain, which often correlates to the menstrual cycle, but a woman with endometriosis may also experience pain that doesn't correlate to her cycle. For many women, the pain of endometriosis is so severe and debilitating that it significantly impacts their daily lives.

It is estimated that seven to 10 percent of all women are affected by endometriosis, including 70 to 87 percent of women with chronic pelvic pain and 30 to 40 percent of all infertile women. Chronic pelvic pain, dysmenorrhea (painful periods) and dyspareunia (painful intercourse) are common symptoms of women with endometriosis. There are several medical treatment options, including danazol, GnRH agonists and progestins, each of which have limitations associated with patient response, tolerability, side-effect profile and duration of treatment.

About Femathina(TM) (MPI-674) and MPI-676

Femathina(TM) (MPI-674) and MPI-676 are based on anastrozole, an aromatase inhibitor (AI) with well-established, multi-year chronic safety and tolerability data. AIs are a class of drugs that reduce the amount of estrogen circulating in the body by binding to and inhibi
'/>"/>

SOURCE Meditrina Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology
2. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
3. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
4. Jazz Pharmaceuticals, Inc. Completes Enrollment in First of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia
5. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
6. Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 2008
7. Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets
8. Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate
9. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
10. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
11. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... N.Y. , May 22, 2013  MGT Capital ... Company will present at the Second Annual Marcum LLP ... New York City at the Grand ... and Chief Executive Officer, will update investors and answer ... The Company,s presentation is scheduled to begin at ...
(Date:5/22/2013)... 2013 Hemoglobin A1C levels increased over ... 2 diabetes, while modest improvements in A1C control ... can lead to substantial healthcare cost savings, according ... for Pharmacoeconomics and Outcomes Research (ISPOR) 18th Annual ... by Valeritas, makers of the V-Go ® ...
(Date:5/22/2013)... 22, 2013   Life Line Screening  (LLS), ... today the creation of a unique partnership with ... MCM is a population health management organization. LLS ... of clients. These important expanded services will help MCM ... Effective prevention reduces cost of care when individuals are ...
Breaking Medicine Technology:MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 3MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 4Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 2Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 3Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 4Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 5Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 6Life Line Screening and MCM Solutions for Better Health Announce New Partnership 2
... 17, 2011 CVS Caremark (NYSE: CVS ... the position of President for Accordant Health Services, a ... management services for people with rare chronic conditions.  Murphy ... management programs with its specialty pharmacy programs and new ...
... Nov. 17, 2011 Global performance improvement solutions provider ... of GP Strategies Corporation (NYSE: GPX ), ... with INERCO (Seville, Spain), a ... and refining facilities with advanced combustion control technologies to ...
Cached Medicine Technology:CVS Caremark Appoints Kevin Murphy President of Accordant Business 2GP and INERCO Form Strategic Alliance to Assist Clients with Optimizing Fuel Costs and Decreasing Emissions 2GP and INERCO Form Strategic Alliance to Assist Clients with Optimizing Fuel Costs and Decreasing Emissions 3
(Date:5/23/2013)... To help members more easily ... pleased to announce integration of its advanced ... new upgrade automatically transfers real-time step data onto ... their company’s team standings, view progress on rewards, ... , Walkingspree also offers an integrated nutritional module ...
(Date:5/23/2013)... is pleased to announce the launch of BeatRUN™, an iPhone ... an iTunes library while running, walking, or on a treadmill. ... as a BPM remote, the app allows instructors to play ... in sync to match their fitness course. Featuring a fresh ... to the perfect beat and ensures their music will adjust ...
(Date:5/23/2013)... 2013 Great defined abs are the embodiment ... strives to achieve in the gym yet so many fall ... make this goal become a reality. Great abdominal muscles are ... time overlooked. Scott Tischler of Tischler Brothers Fitness explains four ... the goal of great abs. , 1.    Go to bed early. ...
(Date:5/23/2013)... May 23, 2013 Group Home Buy ... home buyers were taken on a tour of the latest ... people to purchase houses in groups, thus availing a concession ... charge a nominal fee from the home buyers for the ... the only source of revenue for Group Home Buy will ...
(Date:5/23/2013)... 2013 Kitchen on Fire ... the most advanced culinary technique series currently offered at ... the knowledge of how to purchase, butcher and cook ... benefits of organic, local ingredients. The new Intermediate Series ... hours each. The next series begins on Sunday, June ...
Breaking Medicine News(10 mins):Health News:Walkingspree Expands Device Options with Fitbit to Increase Member Engagement in Corporate Wellness Programs 2Health News:Walkingspree Expands Device Options with Fitbit to Increase Member Engagement in Corporate Wellness Programs 3Health News:Kilo-Beat™ Launches “BeatRUN” App– Now Available on the App Store 2Health News:Scott Tischler of Tischler Brothers Fitness Unveils the 4 Secrets to Getting Abs this Summer 2Health News:Group Home Buy, a Unique Facility for Home Buyers, Launched in Style 2Health News:Kitchen on Fire Launches Intermediate Cooking Series, Advancing the Culinary Skills of Experienced Home Chefs 2Health News:Kitchen on Fire Launches Intermediate Cooking Series, Advancing the Culinary Skills of Experienced Home Chefs 3
... from Boston Medical Centers (BMC) New England Centenarian ... their centenarian subjects, avoiding age-related diseases (i.e. stroke, ... to their longevity; rather, the avoidance of disability ... survival. These findings appear in the February 11th ...
... DIEGO, Feb. 11 SpectraScience, Inc. (OTC,Bulltetin ... devices company, today,announced that it has retained ... consulting firm to provide strategic investor relations,services., ... SpectraScience, stated, "We,have selected Hayden Communications because ...
... Call Center Activated ... to Support Recovery Efforts, NASHVILLE, ... of AT&T Inc. (NYSE: T ),today made a $60,000 ... the victims of this disaster, AT&T is,working with the Tennessee ...
... developed at MIT can deliver controlled drug doses to ... as a micro pharmacy. , The film could eventually ... and other diseases. It is among the first drug-delivery ... small electric field. , You can mete out what ...
... Inc. (Nasdaq:,ICAD), an industry-leading provider of Computer-Aided Detection ... announced that the,Company,s fourth quarter and year end ... on Thursday, March 6, 2008. iCAD management,will discuss ... 10:00 am,ET., Shareholders and other interested parties ...
... Part of MedCath,s Growth Plans, CHARLOTTE, N.C., Feb. ... physician partners today announced plans to double,the number of ... a 120-bed acute care and heart hospital., The ... into 60 inpatient beds, which will be used to ...
Cached Medicine News:Health News:Researchers at BMC find disability does not necessarily follow disease in living to old age 2Health News:SpectraScience, Inc. Retains Hayden Communications 2Health News:AT&T Tennessee Supports Local Disaster Relief Efforts 2Health News:AT&T Tennessee Supports Local Disaster Relief Efforts 3Health News:MIT develops thin-film 'micro pharmacy' 2Health News:iCAD To Release Fourth Quarter and Year End 2007 Financial Results on Thursday, March 6, 2008 2Health News:iCAD To Release Fourth Quarter and Year End 2007 Financial Results on Thursday, March 6, 2008 3Health News:MedCath Plans 60-bed Expansion at TexSAn Heart Hospital 2Health News:MedCath Plans 60-bed Expansion at TexSAn Heart Hospital 3
... The Leica CM1850 cryostat for ... histopathology laboratory is designed for ... workload. A new insulation technology ... the refrigerating system and maintains ...
... in the field of point of diagnostics pathology, ... a back-up instrument in routine pathology laboratories. With ... for the cover, the CM1100 can be transported ... transformer, it can be run on a car ...
... Bright Starlet is the world's smallest cryostat! It ... a choice of handwheel or lever operation. The ... and resist common decontaminating agents. An insulated cover ... refrigeration system and to reduce frosting when the ...
The HM 550 series is a uniquely progressive concept for use with frozen specimens of all types. User applications define module selection and make even serial sectioning enjoyable....
Medicine Products: